# The 0.65-Point Gap That Europe Used to Reject a Duchenne Gene Therapy

- slug: the-065-point-gap-that-europe-used-to-reject-a-duchenne-gene-therapy
- date: 2026-04-16
- category: Biotech & Life Sciences

Europe rejected a Duchenne gene therapy because of a 0.65-point difference on a motor test. But boys with the disease lose 3-8 points per year. Roche is running a new trial in 100 young boys, hoping longer data changes the calculation.

---